Microglial CD44 expression is elevated following stroke (Sawada et al., 2020), ALS (Sawada et al., 2020), glioma (Du et al., 2022), and Alzheimer’s disease (Rangaraju et al., 2018). The gene discussed is CD44; the disease is stroke disorder.